Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Assets (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Assets for 4 consecutive years, with 0.22% as the latest value for Q4 2025.

  • For Q4 2025, Return on Assets rose 13.0% year-over-year to 0.22%; the TTM value through Dec 2025 reached 0.22%, up 13.0%, while the annual FY2025 figure was 0.2%, 0.0% changed from the prior year.
  • Return on Assets was 0.22% for Q4 2025 at Day One Biopharmaceuticals, up from 0.29% in the prior quarter.
  • The five-year high for Return on Assets was 0.18% in Q2 2025, with the low at 0.76% in Q2 2024.
  • Historically, Return on Assets has averaged 0.4% across 4 years, with a median of 0.39% in 2022.
  • The largest annual shift saw Return on Assets plummeted -33bps in 2024 before it skyrocketed 58bps in 2025.
  • Over 4 years, Return on Assets stood at 0.39% in 2022, then fell by -23bps to 0.48% in 2023, then rose by 28bps to 0.35% in 2024, then surged by 37bps to 0.22% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.22% in Q4 2025, 0.29% in Q3 2025, and 0.18% in Q2 2025.